← Back to Search

Behavioral Intervention

Sleep Health Interventions for Shift Work Sleep Disorder (OSHIN Trial)

N/A
Recruiting
Led By Jessica Dietch, PhD
Research Sponsored by Oregon State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the post-treatment assessment (occurring at approximately 10 weeks)
Awards & highlights
No Placebo-Only Group

Summary

This trial will test two methods to help nurses with insomnia from working night shifts.

Who is the study for?
This trial is for night shift working nurses in Oregon who have insomnia or sleep issues and expect to keep their schedule during the study. They must be able to use the internet daily and read/write English. Nurses on certain insomnia treatments, with uncontrolled medical conditions, seizure history, safety risks, or expecting pregnancy can't join.
What is being tested?
The study tests two behavioral strategies for better sleep among nurses working at night: Cognitive Behavioral Therapy for Insomnia (CBTI) and Morning Routine Therapy for Insomnia (MRTI). It aims to see which helps improve sleep quality.
What are the potential side effects?
Since CBTI and MRTI are non-medical interventions focusing on behavior changes rather than drugs, they typically don't have physical side effects. However, participants may experience temporary increases in stress or anxiety as they adjust their routines.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the post-treatment assessment (occurring at approximately 10 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at the post-treatment assessment (occurring at approximately 10 weeks) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Insomnia Severity Index
Implementation Assessment Measure
Retention Rate
+1 more
Secondary study objectives
Change in Fatigue Severity Scale
Change in PROMIS Sleep Related Impairment 8 item

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: MRTIExperimental Treatment1 Intervention
Multicomponent Relaxation Therapy for Insomnia
Group II: CBTIExperimental Treatment1 Intervention
Cognitive Behavioral Therapy for Insomnia
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CBTI
2016
Completed Phase 2
~130

Find a Location

Who is running the clinical trial?

Monash UniversityOTHER
200 Previous Clinical Trials
10,573,782 Total Patients Enrolled
Stanford UniversityOTHER
2,491 Previous Clinical Trials
17,519,152 Total Patients Enrolled
20 Trials studying Insomnia
4,175 Patients Enrolled for Insomnia
American Academy of Sleep MedicineOTHER
25 Previous Clinical Trials
2,830 Total Patients Enrolled
5 Trials studying Insomnia
380 Patients Enrolled for Insomnia
Oregon State UniversityLead Sponsor
50 Previous Clinical Trials
8,374 Total Patients Enrolled
1 Trials studying Insomnia
50 Patients Enrolled for Insomnia
Jessica Dietch, PhDPrincipal InvestigatorOregon State University
1 Previous Clinical Trials
60 Total Patients Enrolled

Media Library

CBTI (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05965609 — N/A
Insomnia Research Study Groups: CBTI, MRTI
Insomnia Clinical Trial 2023: CBTI Highlights & Side Effects. Trial Name: NCT05965609 — N/A
CBTI (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05965609 — N/A
~0 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top